Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl

Detalhes bibliográficos
Autor(a) principal: Dinakaran, Sathis Kumar
Data de Publicação: 2011
Outros Autores: Kumar, Santhos, Banji, David, Avasarala, Harani, Rao, Venkateshwar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/10915
Resumo: The purpose of this research study was to establish ziprasidone HCl NR 40 mg and trihexyphenidyl HCl SR 4mg in the form of bi-layer sustained release floating tablets. The tablets were prepared using sodium HPMC K4M / HPMC K15M as bio-adhesive polymers and sodium bicarbonate acting as a floating layer. Tablets were evaluated based on different parameters such as thickness, hardness, friability, weight variation, in vitro dissolution studies, content of active ingredient and IR studies. The physico-chemical properties of the finished product complied with the specifications. In vitro release from the formulation was studied as per the USP XXIII dissolution procedure. The formulations gave a normal release effect followed by sustained release for 12 h which indicates bimodal release of ziprasidone HCl from the matrix tablets. The data obtained was fitted to Peppas models. Analysis of n values of the Korsmeyer equation indicated that the drug release involved non-diffusional mechanisms. By the present study, it can be concluded that bi-layer tablets of ziprasidone HCl and trihexyphenidyl HCl will be a useful strategy for extending the metabolism and improving the bioavailability of Ziprasidone HCl and Trihexyphenidyl HCl.
id USP-31_445b9df586b57737187d0c80515e9d50
oai_identifier_str oai:revistas.usp.br:article/10915
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl Comprimidos bicamadaZiprasidona.HCl.Triexifenidila.HCl.Liberação controladaBi-layer tabletZiprasidone HClTrihexyphenidyl HClSustained release The purpose of this research study was to establish ziprasidone HCl NR 40 mg and trihexyphenidyl HCl SR 4mg in the form of bi-layer sustained release floating tablets. The tablets were prepared using sodium HPMC K4M / HPMC K15M as bio-adhesive polymers and sodium bicarbonate acting as a floating layer. Tablets were evaluated based on different parameters such as thickness, hardness, friability, weight variation, in vitro dissolution studies, content of active ingredient and IR studies. The physico-chemical properties of the finished product complied with the specifications. In vitro release from the formulation was studied as per the USP XXIII dissolution procedure. The formulations gave a normal release effect followed by sustained release for 12 h which indicates bimodal release of ziprasidone HCl from the matrix tablets. The data obtained was fitted to Peppas models. Analysis of n values of the Korsmeyer equation indicated that the drug release involved non-diffusional mechanisms. By the present study, it can be concluded that bi-layer tablets of ziprasidone HCl and trihexyphenidyl HCl will be a useful strategy for extending the metabolism and improving the bioavailability of Ziprasidone HCl and Trihexyphenidyl HCl. O propósito deste trabalho foi preparar ziprasidona. HCl NR 40 mg e triexifenidila.HCl SR 4 mg na forma de comprimidos efervescentes bicamada de liberação controlada. Os comprimidos foram preparados utilizando HPMC K4M / HPMC K15M sódico como polímero bioadesivo e bicarbonato como camada efervescente. Os comprimidos foram avaliados quanto a diferentes parâmetros, como espessura, dureza, friabilidade, variação de peso, dissolução in vitro, conteúdo do ingrediente ativo e estudos de IV. As propriedades físico-químicas dos produtos finais cumprem as especificações. A liberação in vitro da formulação foi estudada de acordo com o procedimento de dissolução da USP XXIII. As formulações resultaram em liberação normal, seguida por liberação controlada por 12 h, o que indica a liberação bimodal de cloridrato de ziprasidona dos comprimidos matriz. Os dados obtidos se adequaram aos modelos de Peppas. A análise de valores de n da equação de Korsmeyer indicou que a liberação do fármaco envolveu mecanismos não difusionais. Por este estudo, pode-se concluir que os comprimidos bicamada de ziprasidona.HCl e de triexifenidila.HCl serão um bom caminho para estender o metabolismo e para melhorar a biodisponibilidade de ziprasidona.HCl e de triexifenidila.HCl. Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2011-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/1091510.1590/S1984-82502011000300012Brazilian Journal of Pharmaceutical Sciences; Vol. 47 No. 3 (2011); 545-553 Brazilian Journal of Pharmaceutical Sciences; v. 47 n. 3 (2011); 545-553 Brazilian Journal of Pharmaceutical Sciences; Vol. 47 Núm. 3 (2011); 545-553 2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/10915/12683Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessDinakaran, Sathis KumarKumar, SanthosBanji, DavidAvasarala, HaraniRao, Venkateshwar2012-05-12T16:12:48Zoai:revistas.usp.br:article/10915Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2012-05-12T16:12:48Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
title Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
spellingShingle Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
Dinakaran, Sathis Kumar
Comprimidos bicamada
Ziprasidona.HCl.
Triexifenidila.HCl.
Liberação controlada
Bi-layer tablet
Ziprasidone HCl
Trihexyphenidyl HCl
Sustained release
title_short Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
title_full Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
title_fullStr Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
title_full_unstemmed Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
title_sort Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
author Dinakaran, Sathis Kumar
author_facet Dinakaran, Sathis Kumar
Kumar, Santhos
Banji, David
Avasarala, Harani
Rao, Venkateshwar
author_role author
author2 Kumar, Santhos
Banji, David
Avasarala, Harani
Rao, Venkateshwar
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Dinakaran, Sathis Kumar
Kumar, Santhos
Banji, David
Avasarala, Harani
Rao, Venkateshwar
dc.subject.por.fl_str_mv Comprimidos bicamada
Ziprasidona.HCl.
Triexifenidila.HCl.
Liberação controlada
Bi-layer tablet
Ziprasidone HCl
Trihexyphenidyl HCl
Sustained release
topic Comprimidos bicamada
Ziprasidona.HCl.
Triexifenidila.HCl.
Liberação controlada
Bi-layer tablet
Ziprasidone HCl
Trihexyphenidyl HCl
Sustained release
description The purpose of this research study was to establish ziprasidone HCl NR 40 mg and trihexyphenidyl HCl SR 4mg in the form of bi-layer sustained release floating tablets. The tablets were prepared using sodium HPMC K4M / HPMC K15M as bio-adhesive polymers and sodium bicarbonate acting as a floating layer. Tablets were evaluated based on different parameters such as thickness, hardness, friability, weight variation, in vitro dissolution studies, content of active ingredient and IR studies. The physico-chemical properties of the finished product complied with the specifications. In vitro release from the formulation was studied as per the USP XXIII dissolution procedure. The formulations gave a normal release effect followed by sustained release for 12 h which indicates bimodal release of ziprasidone HCl from the matrix tablets. The data obtained was fitted to Peppas models. Analysis of n values of the Korsmeyer equation indicated that the drug release involved non-diffusional mechanisms. By the present study, it can be concluded that bi-layer tablets of ziprasidone HCl and trihexyphenidyl HCl will be a useful strategy for extending the metabolism and improving the bioavailability of Ziprasidone HCl and Trihexyphenidyl HCl.
publishDate 2011
dc.date.none.fl_str_mv 2011-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10915
10.1590/S1984-82502011000300012
url https://www.revistas.usp.br/bjps/article/view/10915
identifier_str_mv 10.1590/S1984-82502011000300012
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10915/12683
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 47 No. 3 (2011); 545-553
Brazilian Journal of Pharmaceutical Sciences; v. 47 n. 3 (2011); 545-553
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 Núm. 3 (2011); 545-553
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1787713367526342656